Notch1 Stimulation Induces a Vascularization Switch With Pericyte‐Like Cell Differentiation of Glioblastoma Stem Cells

Glioblastoma multiforms (GBMs) are highly vascularized brain tumors containing a subpopulation of multipotent cancer stem cells. These cells closely interact with endothelial cells in neurovascular niches. In this study, we have uncovered a close link between the Notch1 pathway and the tumoral vascularization process of GBM stem cells. We observed that although the Notch1 receptor was activated, the typical target proteins (HES5, HEY1, and HEY2) were not or barely expressed in two explored GBM stem cell cultures. Notch1 signaling activation by expression of the intracellular form (NICD) in these cells was found to reduce their growth rate and migration, which was accompanied by the sharp reduction in neural stem cell transcription factor expression (ASCL1, OLIG2, and SOX2), while HEY1/2, KLF9, and SNAI2 transcription factors were upregulated. Expression of OLIG2 and growth were restored after termination of Notch1 stimulation. Remarkably, NICD expression induced the expression of pericyte cell markers (NG2, PDGFRβ, and α‐smooth muscle actin [αSMA]) in GBM stem cells. This was paralleled with the induction of several angiogenesis‐related factors most notably cytokines (heparin binding epidermal growth factor [HB‐EGF], IL8, and PLGF), matrix metalloproteinases (MMP9), and adhesion proteins (vascular cell adhesion molecule 1 [VCAM1], intercellular adhesion molecule 1 [ICAM1], and integrin alpha 9 [ITGA9]). In xenotransplantation experiments, contrasting with the infiltrative and poorly vascularized tumors obtained with control GBM stem cells, Notch1 stimulation resulted in poorly disseminating but highly vascularized grafts containing large vessels with lumen. Notch1‐stimulated GBM cells expressed pericyte cell markers and closely associated with endothelial cells. These results reveal an important role for the Notch1 pathway in regulating GBM stem cell plasticity and angiogenic properties. Stem Cells 2015;33:21–34

[1]  Diane D. Liu,et al.  A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells , 2014, Stem cells.

[2]  H. Poulsen,et al.  Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures , 2013, Cancer biology & therapy.

[3]  R. McLendon,et al.  Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.

[4]  H. Duffau,et al.  Cell death and neuronal differentiation of glioblastoma stem‐like cells induced by neurogenic transcription factors , 2013, Glia.

[5]  Y. St-Pierre,et al.  Epigenetic regulation of mmp-9 gene expression , 2012, Cellular and Molecular Life Sciences.

[6]  K. Plate,et al.  Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited , 2012, Acta Neuropathologica.

[7]  Payam Shahi,et al.  Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity. , 2012, Cell stem cell.

[8]  D. Zagzag,et al.  Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.

[9]  K. G. Guruharsha,et al.  The Notch signalling system: recent insights into the complexity of a conserved pathway , 2012, Nature Reviews Genetics.

[10]  J. Rich,et al.  The Quest for Self-Identity: Not All Cancer Stem Cells Are the Same , 2012, Clinical Cancer Research.

[11]  T. Dawson,et al.  Botch promotes neurogenesis by antagonizing Notch. , 2012, Developmental cell.

[12]  D. Castel,et al.  A Critical Requirement for Notch Signaling in Maintenance of the Quiescent Skeletal Muscle Stem Cell State , 2012, Stem cells.

[13]  Tom H. Cheung,et al.  Notch Signaling Is Necessary to Maintain Quiescence in Adult Muscle Stem Cells , 2012, Stem cells.

[14]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[15]  B. Sullenger,et al.  Notch signaling in cancer stem cells. , 2012, Advances in experimental medicine and biology.

[16]  T. Kume.  Ligand-dependent Notch signaling in vascular formation. , 2012, Advances in experimental medicine and biology.

[17]  H. Poulsen,et al.  Notch signaling and brain tumors. , 2012, Advances in experimental medicine and biology.

[18]  J. Rich,et al.  Twisted tango: brain tumor neurovascular interactions , 2011, Nature Neuroscience.

[19]  Iannis Aifantis,et al.  Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think , 2011, The Journal of experimental medicine.

[20]  F. DiMeco,et al.  Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. , 2011, Cancer research.

[21]  H. Fine,et al.  Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy , 2011, Glia.

[22]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[23]  Chao Wang,et al.  siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth , 2011, Molecular Biology Reports.

[24]  M. Westphal,et al.  A distinct subset of glioma cell lines with stem cell‐like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target , 2011, Glia.

[25]  Y. Funahashi,et al.  Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity , 2011, Vascular cell.

[26]  C. Beier,et al.  CD133 negative cancer stem cells in glioblastoma. , 2011, Frontiers in bioscience.

[27]  R. Bischoff,et al.  Physiology and pathophysiology of matrix metalloproteases , 2010, Amino Acids.

[28]  L. Di Marcotullio,et al.  The multiple functions of Numb. , 2010, Experimental cell research.

[29]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[30]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[31]  A. Wagers,et al.  Notch signaling in the regulation of stem cell self-renewal and differentiation. , 2010, Current topics in developmental biology.

[32]  K. Hirschi,et al.  Diverse roles of the vasculature within the neural stem cell niche. , 2009, Regenerative medicine.

[33]  Yihai Cao,et al.  Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature , 2009, Proceedings of the National Academy of Sciences.

[34]  Holger Gerhardt,et al.  Angiogenesis: a team effort coordinated by notch. , 2009, Developmental cell.

[35]  Paolo Malatesta,et al.  SOX2 Silencing in Glioblastoma Tumor‐Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity , 2009, Stem cells.

[36]  Ling Lin,et al.  TGF‐α induces upregulation and nuclear translocation of Hes1 in glioma cell , 2008, Cell biochemistry and function.

[37]  S. Vandenberg,et al.  Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. , 2008, Neuro-oncology.

[38]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[39]  Brendan H. Lee,et al.  Dimorphic effects of Notch signaling in bone homeostasis , 2008, Nature Medicine.

[40]  N. Gaiano,et al.  Differential Notch signalling distinguishes neural stem cells from intermediate progenitors. , 2007, Nature.

[41]  G. Zheng,et al.  Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells , 2007, Molecular and Cellular Biochemistry.

[42]  T. Gridley.  Notch signaling in vascular development and physiology , 2007, Development.

[43]  Mitchel S Berger,et al.  Contribution of Notch signaling activation to human glioblastoma multiforme. , 2007, Journal of neurosurgery.

[44]  N. Feldman,et al.  Endostatin: Current concepts about its biological role and mechanisms of action , 2007, Biochemistry (Moscow).

[45]  Hongye Liu,et al.  Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant Glioma , 2007, Neuron.

[46]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[47]  Minhong Yan,et al.  Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.

[48]  Gavin Thurston,et al.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.

[49]  I. Jonassen,et al.  Angiogenesis-independent tumor growth mediated by stem-like cancer cells , 2006, Proceedings of the National Academy of Sciences.

[50]  D. Trono,et al.  Production and Titration of Lentiviral Vectors , 2006, Current protocols in neuroscience.

[51]  A. Harris,et al.  Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder Cancer , 2006, Clinical Cancer Research.

[52]  Zhiwei Wang,et al.  Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. , 2006, Cancer research.

[53]  Erwin G. Van Meir,et al.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.

[54]  Q. Su,et al.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.

[55]  Jeffrey L. Wrana,et al.  Turning it up a Notch: cross-talk between TGFβ and Notch signaling , 2005 .

[56]  J. Wrana,et al.  Turning it up a Notch: cross-talk between TGF beta and Notch signaling. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57]  P. Ongusaha,et al.  HB-EGF Is a Potent Inducer of Tumor Growth and Angiogenesis , 2004, Cancer Research.

[58]  U. Lendahl,et al.  Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation , 2003, Development.

[59]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[60]  Tasuku Honjo,et al.  Notch1 and Notch3 Instructively Restrict bFGF-Responsive Multipotent Neural Progenitor Cells to an Astroglial Fate , 2001, Neuron.

[61]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[62]  M. Schwab,et al.  A metalloprotease activity from C6 glioma cells inactivates the myelin-associated neurite growth inhibitors and can be neutralized by antibodies. , 1998, British Journal of Cancer.

[63]  K. Mishima,et al.  Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas , 1998, Acta Neuropathologica.